BRIGHT ROCK CAPITAL MANAGEMENT, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIGHT ROCK CAPITAL MANAGEMENT, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$1,431,090
+12.4%
9,0000.0%0.35%
+17.8%
Q2 2023$1,273,140
-16.0%
9,0000.0%0.30%
-21.6%
Q1 2023$1,515,240
+99325.2%
9,0000.0%0.38%
-4.1%
Q4 2022$1,524
-99.9%
9,0000.0%0.40%
-16.3%
Q3 2022$1,684,000
+15.2%
9,0000.0%0.47%
+19.5%
Q2 2022$1,462,0009,0000.40%
Other shareholders
REPLIGEN CORP shareholders Q3 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders